Most patients treated with erenumab in clinical practice have chronic migraine (CM). We assessed the rate and possible predictors of conversion from CM to episodic migraine (EM) in a real-life study.
Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
Ornello, Raffaele;Frattale, Ilaria;Caponnetto, Valeria;Marini, Carmine;Pistoia, Francesca;Sacco, Simona
2020-01-01
Abstract
Most patients treated with erenumab in clinical practice have chronic migraine (CM). We assessed the rate and possible predictors of conversion from CM to episodic migraine (EM) in a real-life study.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s10194-020-01171-w.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
806.19 kB
Formato
Adobe PDF
|
806.19 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
